← Back to Healthcare Triangle, Inc.
Stoqly stoqly.net Company report Β· October 27, 2026

Healthcare Triangle, Inc.

HCTI NasdaqΒ· Services-Computer Integrated Systems Design

Last close Β· Oct 27, 2026

$6.80

KIRA Β· Stoqly’s AI analyst, in plain words

  • Healthcare Triangle, Inc. had $13.9M of revenue in fiscal 2025, up 18.8% on the year before. Over five years, revenue changed βˆ’15.0% a year on average.
  • Its operating margin was βˆ’70.5%, down 29.8Β pts: of every 100 in sales, about βˆ’70 is left after running the business.
  • Healthcare Triangle, Inc. lost $9.5M in fiscal 2025.
  • Free cash flow was βˆ’$16.5M in fiscal 2025, βˆ’119.0% of revenue.
  • Healthcare Triangle, Inc. owes $3.1M more than it holds in cash.

Market cap

$19.1M

P/E

β€”

Revenue

$13.9M

Net income

βˆ’$9.5M

Free cash flow

βˆ’$16.5M

Operating margin

βˆ’70.5%

Healthcare Triangle, Inc. in 30 seconds Β· fiscal 2025

Good

Are sales growing?

+18.8%

Yes. Sales grew 18.8% last year.

Weak

Does it make a profit?

βˆ’68.2%

No. It lost money last year.

Weak

Does profit turn into cash?

βˆ’119.0%

No. It spent more cash than it brought in.

Weak

How healthy are the accounts?

3 / 9

Weak. It passes 3 of 9 health tests.

For information

How is the share priced?

β€”

No P/E: it made no profit over the last four quarters.

What Healthcare Triangle, Inc. does

No business description yet.

Fiscal year ends
December 31, 2025
Latest annual report
10-K Β· Apr 15, 2026
Legal name
Healthcare Triangle, Inc.
CIK
0001839285
stoqly.net Β· HCTI Β· Generated October 27, 2026 Not investment advice Β· Page 1 of 3
Stoqly stoqly.net Company report Β· October 27, 2026

Healthcare Triangle, Inc. Β· HCTI

Results and finances

The last 5 fiscal years. Amounts in USD.

Fiscal yearFY21FY22FY23FY24FY25
Sales and profit
Revenue $35.3M $45.9M $33.2M $11.7M $13.9M
Revenue growth 12.5% 30.1% βˆ’27.6% βˆ’64.8% 18.8%
Net interest income βˆ’$0.6M βˆ’$0.2M βˆ’$1.0M βˆ’$1.2M βˆ’$0.6M
Gross margin 29.8% 24.6% 3,222.6% 9,148.4% 8,890.6%
Operating margin βˆ’15.2% βˆ’35.6% βˆ’23.2% βˆ’40.6% βˆ’70.5%
Net income βˆ’$5.9M βˆ’$14.4M βˆ’$8.7M βˆ’$6.0M βˆ’$9.5M
Net margin βˆ’16.9% βˆ’31.3% βˆ’26.2% βˆ’51.0% βˆ’68.2%
Diluted EPS βˆ’$0.20 βˆ’$3.88 βˆ’$2.08 βˆ’$16,909.30 βˆ’$152.30
Cash
Cash from operations βˆ’$7.1M βˆ’$5.4M βˆ’$2.2M βˆ’$1.1M βˆ’$16.5M
Capital expenditure β€” $0.0M $0.0M β€” $0.0M
Free cash flow β€” βˆ’$5.4M βˆ’$2.2M β€” βˆ’$16.5M
FCF margin β€” βˆ’11.8% βˆ’6.5% β€” βˆ’119.0%
Share buybacks β€” $0.1M β€” β€” β€”
Share count change 5.5% βˆ’87.4% 13.0% βˆ’100.0% 15,375.0%
Debt and strength
Cash and short-term investments $1.8M $1.3M $1.2M $0.0M $7.6M
Debt incl. finance leases $2.2M $2.7M $4.7M $2.7M $10.7M
Shareholders' equity $14.2M $6.0M $0.5M βˆ’$5.1M $9.9M
Current ratio 1.9x 1.2x 0.7x 0.2x 1.0x
Interest coverage βˆ’9.4x βˆ’77.0x βˆ’7.9x β€” βˆ’17.3x
Returns and quality
Return on capital βˆ’28.8% βˆ’174.6% βˆ’152.7% β€” βˆ’59.2%
Return on equity βˆ’64.1% βˆ’141.6% βˆ’264.1% β€” βˆ’392.4%
Return on tangible equity βˆ’238.6% βˆ’2,155.9% β€” β€” 225.0%
Piotroski F-score 2 3 3 4 3
Altman Z'' 1.4 βˆ’11.3 βˆ’23.0 βˆ’91.7 βˆ’8.1

Insiders bought, 12 months

$0.0M

0 insiders

Insiders sold, 12 months

$0.0M

0 insiders

Of sales under plans

β€”

$0.0M

How to read these numbers

Revenue:
Total sales reported in the income statement.
Operating margin:
Operating income as a share of revenue.
Net income:
Profit after all expenses, interest and tax.
Free cash flow:
Cash from operations minus capital spending.
Net debt / EBITDA:
Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
Return on capital:
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
stoqly.net Β· HCTI Β· Generated October 27, 2026 Not investment advice Β· Page 2 of 3
Stoqly stoqly.net Company report Β· October 27, 2026

Healthcare Triangle, Inc. Β· HCTI

Charts and comparison

Ten years at a glance, and how it stacks up against similar companies.

Revenue

Net income

Margins, % of revenue

Gross Operating Net

Cash vs debt (incl. leases)

Cash Debt

Free cash flow

Dividends and buybacks

Dividends Buybacks

KIRA

At $6.80 a share, the company is worth $19.1M.

Source: SEC EDGAR XBRL filings (CIK 0001839285). Data updated October 24, 2026. For information only β€” not investment advice. Check the original filings before relying on any figure.